Table 4 Summary of the mean radiobiological parameters for patients with specific cancer type
Cancer type | \(T_{{\text{t}}}\) (days) | \(T_{p}\) (days) | \(T_{{\text{k}}}\) (days) | \(\alpha\) (Gy−1) | \(\alpha {/}\beta\) (Gy) | BED (Gy) | TCP (%) | \(\Delta {\text{TLG}}_{{{\text{liver}}}}\)(%) |
|---|---|---|---|---|---|---|---|---|
Breast | 52.0 ± 3.0 COV ≈ 6% | 152 ± 28 COV ≈ 18% | 39.1 ± 15.9 COV ≈ 41% | 0.045 ± 0.036 COV ≈ 80% | 3.0 ± 2.0 COV ≈ 67% | 67.2 ± 25.8 COV ≈ 38% | 60.4 ± 18.7 COV ≈ 31% | 66.3 ± 22.3 COV ≈ 34% |
NET | 45.3 ± 5.1 COV ≈ 11% | 162 ± 33 COV ≈ 20% | 32.1 ± 9.5 COV ≈ 30% | 0.33 ± 0.18 COV ≈ 55% | 7.87 ± 2.0 COV ≈ 25% | 106.7 ± 54.1 COV ≈ 51% | 46.8 ± 12.0 COV ≈ 26% | 50.7 ± 13.1 COV ≈ 26% |
CRC | 49.4 ± 2.4 COV ≈ 5% | 129 ± 19 COV ≈15% | 23.5 ± 8.3 COV ≈ 35% | 0.010 ± 0.005 COV ≈ 50% | 14.1 ± 8.9 COV ≈ 63% | 36.0 ± 15.3 COV ≈ 43% | 28.2 ± 12.7 COV ≈ 45% | 7.7 ± 33.1 COV ≈ 430% |
Cholangiocarcinoma | 46.3 ± 1.4 COV ≈ 3% | 236 ± 67.2 COV ≈ 28% | 28.3 ± 10.5 COV ≈ 37% | 0.040 ± 0.022 COV ≈ 55% | 2.38 ± 1.21 COV ≈ 51% | 45.7 ± 12.8 COV ≈ 28% | 53.1 ± 16.6 COV ≈ 31% | 63.5 ± 18.0 COV ≈ 28% |
Others | 53.8 ± 3.6 COV ≈ 7% | 174 ± 24 COV ≈ 14 | 32.2 ± 6.2 COV ≈ 19% | 0.100 ± 0.040 COV ≈ 40% | 4.28 ± 0.94 COV ≈ 22% | 40.9 ± 11.5 COV ≈ 28% | 35.3 ± 9.5 COV ≈ 27% | 42.9 ± 11.0 COV ≈ 26% |